Jérôme Busserolles Selected Research

Cold Hypersensitivity

1/2018	Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.
5/2011	Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jérôme Busserolles Research Topics

Disease

13	Pain (Aches) 12/2023 - 01/2011
11	Peripheral Nervous System Diseases (PNS Diseases) 12/2023 - 03/2012
8	Neuralgia (Stump Neuralgia) 12/2023 - 02/2016
6	Hypersensitivity (Allergy) 05/2022 - 01/2011
4	Neoplasms (Cancer) 05/2022 - 03/2012
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2018
3	Hyperalgesia 12/2023 - 03/2012
3	Chronic Pain 01/2016 - 01/2013
3	Inflammation (Inflammations) 08/2015 - 05/2005
2	Multiple Myeloma 04/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 10/2020 - 01/2013
2	Constipation 10/2020 - 01/2013
2	Cold Hypersensitivity 01/2018 - 05/2011
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Channelopathies 12/2021
1	Nociceptive Pain 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Cancer Pain 01/2020
1	Polyps 01/2018
1	Wounds and Injuries (Trauma) 03/2012
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Body Weight (Weight, Body) 01/2006
1	Carcinogenesis 01/2006
1	Colitis 05/2005
1	Hyperlipidemias (Hyperlipidemia) 06/2003
1	Magnesium Deficiency (Deficiency, Magnesium) 03/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2002

Drug/Important Bio-Agent (IBA)

10	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 05/2011
6	Analgesics (Analgesic Drugs)IBA 05/2022 - 01/2016
5	Bortezomib (Velcade)FDA Link 12/2023 - 08/2015
5	Ion Channels (Ion Channel)IBA 12/2021 - 05/2011
4	potassium channel protein TREK-1IBA 01/2018 - 01/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 03/2012
3	Potassium Channels (Potassium Channel)IBA 12/2021 - 02/2016
3	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2019
2	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 05/2022
2	Messenger RNA (mRNA)IBA 07/2021 - 01/2011
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2021 - 06/2020
2	CannabinoidsIBA 01/2021 - 08/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 10/2002
2	AntioxidantsIBA 01/2006 - 10/2002
2	FructoseIBA 06/2003 - 10/2002
2	Sucrose (Saccharose)IBA 03/2003 - 10/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023
1	Indicators and Reagents (Reagents)IBA 12/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2022
1	Cholinergic Agents (Cholinergics)IBA 05/2022
1	Donepezil (Aricept)FDA LinkGeneric 05/2022
1	Histone Deacetylase InhibitorsIBA 12/2021
1	entinostat (MS 275)IBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2020
1	Antidepressive Agents (Antidepressants)IBA 06/2020
1	Riluzole FDA LinkGeneric 01/2018
1	Taxoids (Taxanes)IBA 08/2015
1	PlatinumIBA 08/2015
1	SaltsIBA 08/2015
1	Thalidomide (Thalomid)FDA Link 08/2015
1	Vinca AlkaloidsIBA 08/2015
1	eribulin FDA Link 08/2015
1	Neuroprotective AgentsIBA 08/2015
1	Epothilones (Epothilone)IBA 08/2015
1	Antineoplastic Agents (Antineoplastics)IBA 05/2015
1	Sodium Channels (Sodium Channel)IBA 05/2015
1	Dinoprostone (PGE2)FDA Link 12/2014
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2013
1	Glutamic Acid (Glutamate)FDA Link 11/2013
1	Morphine (MS Contin)FDA LinkGeneric 01/2013
1	Streptozocin (Streptozotocin)FDA Link 03/2012
1	CationsIBA 03/2012
1	Antimitotic AgentsIBA 03/2012
1	NAD (NADH)IBA 03/2012
1	CarrageenanIBA 01/2011
1	Freund's AdjuvantIBA 01/2011
1	BilirubinIBA 01/2006
1	Biliverdine (Biliverdin)IBA 01/2006
1	Heme Oxygenase-1IBA 01/2006
1	procyanidinIBA 01/2006
1	bolinaquinoneIBA 05/2005
1	petrosaspongiolide mIBA 05/2005
1	AcidsIBA 05/2005
1	Triglycerides (Triacylglycerol)IBA 06/2003
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 03/2003
1	Estrogens (Estrogen)FDA Link 10/2002

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 12/2023 - 01/2006
3	Therapeutics 01/2016 - 03/2012
1	Analgesia 01/2013